OPHTHALMISCHE FORMULIERUNG

European patent · EP3761960 · In force

Register entry

Publication number
EP3761960
Application number
EP19708337
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 8, 2019
Published
Jan 13, 2021
Granted
Nov 22, 2023
Protection ends at the latest
Mar 7, 2039
Next annual fee due
Mar 31, 2027
IPC classes
A61K 9/08 (2006.01)
A61K 47/42 (2017.01)
A61K 31/381 (2006.01)
Priority
EP 18160981 09.03.2018
PCT application
PCT/EP2019/055818 08.03.2019
PCT publication
WO2019/170848 12.09.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Oct 2, 2024

    Change

    Published in Swissreg on 02.10.2024

  4. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  5. Mar 21, 2024

    Address changed

    Owner
    Kiora Pharmaceuticals GmbH, Reisnerstraße 34/1, 1030 Wien, Germany → Kiora Pharmaceuticals GmbH, Herrengasse 5/3/6, 1010 Wien, Austria

    Published in Swissreg on 21.03.2024

  6. Nov 22, 2023

    Granted

    Published in Swissreg on 22.11.2023

Parties

Holder

Kiora Pharmaceuticals GmbH

Herrengasse 5/3/6, 1010 Wien, AT

Inventor

SPERL, Stefan

1050 Vienna, AT

OBERMAYR, Franz

1010 Vienna, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.